Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Covington
Boehringer Ingelheim
Cipla
Daiichi Sankyo
Deloitte
US Army
Colorcon
Novartis

Generated: February 22, 2018

DrugPatentWatch Database Preview

ORTHO-NOVUM 1/80 21 Drug Profile

« Back to Dashboard

When do Ortho-novum 1/80 21 patents expire, and when can generic versions of Ortho-novum 1/80 21 launch?

Ortho-novum 1/80 21 is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.

The generic ingredient in ORTHO-NOVUM 1/80 21 is mestranol; norethindrone. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mestranol; norethindrone profile page.
Summary for ORTHO-NOVUM 1/80 21
Drug patent expirations by year for ORTHO-NOVUM 1/80 21

US Patents and Regulatory Information for ORTHO-NOVUM 1/80 21

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm ORTHO-NOVUM 1/80 21 mestranol; norethindrone TABLET;ORAL-21 016715-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Moodys
Fish and Richardson
Baxter
Daiichi Sankyo
Chubb
Cerilliant
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot